Chemo test confusion
Friends saw on Sunrise yesterday morning a story that a dr has started a petition that has thousdands of signatures to get the government to fund this test that costs a lot that will show whether chem...
Forum Discussion
"Who is eligible for the Oncotype DX Breast Recurrence Score Test?
You may be a candidate for the Oncotype DX Breast Recurrence Score Test if:
- you’ve recently been diagnosed with stage I, stage II, or stage IIIa invasive breast cancer
- the cancer is estrogen-receptor-positive
- the cancer is HER2-negative
- the cancer is lymph node-positive or lymph node-negative (meaning you may be eligible for the test whether or not the cancer is in the lymph nodes)
- you and your doctor are making decisions about chemotherapy
Most early-stage, estrogen-receptor-positive, HER2-negative breast cancers are treated with hormonal therapies, such as an aromatase inhibitor or tamoxifen, after surgery to reduce the risk that the cancer will come back in the future. Whether or not chemotherapy is also necessary has been an area of uncertainty for patients and their doctors.
If you’ve been diagnosed with early-stage, estrogen-receptor-positive, HER2-negative breast cancer, the Oncotype DX Breast Recurrence Score Test can help you and your doctor make a more informed decision about whether or not you will benefit from chemotherapy."
https://www.breastcancer.org/symptoms/testing/types/oncotype_dx
Hi @PetraSminsk,
Firstly, good on your for supporting your mum.
I did have the Oncotype DX test and avoided chemo. It is not suitable for all breast cancers, as you will have read above. There are other tests which some of our members here might know more about. Ask the surgeon for a copy of the pathology results, and ask them to explain the type of breast cancer. From that point, you can discuss treatment options.
All the best. xxx